• SENSEX 77,414.92
    -191.51 (--0.25%)
  • BANKNIFTY 51,564.85
    -11.00 (--0.02%)
  • Hind.Aeronautics
    4,294.00 5,675.00(%)
  • Zomato Ltd
    200.50 146.85(%)
  • Aster DM Health.
    504.00 558.30(%)
  • Reliance Industr
    1,269.05 1,156.00(%)
  • Tata Motors
    684.90 1,179.05(%)
  • Jio Financial
    232.25 394.70(%)
  • Mazagon Dock
    2,635.55 920.48(%)
  • Vodafone Idea
    6.77 6.60(%)
  • HDFC Bank
    1,836.40 1,880.00(%)
  • Suzlon Energy
    56.40 37.95(%)
  • M & M
    2,635.10 1,872.45(%)
  • IDFC First Bank
    54.63 52.60(%)
  • Dixon Technolog.
    13,019.00 7,100.05(%)
  • I R F C
    123.65 108.05(%)
  • Bharat Electron
    306.50 340.35(%)
  • Adani Energy Sol
    863.60 588.25(%)
  • Asian Paints
    2,322.35 2,125.00(%)
  • Reliance Power
    44.75 54.25(%)
  • Hindustan Copper
    218.75 195.35(%)
  • IndusInd Bank
    643.70 605.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Brooks Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 40505.0
  • ISIN : INE650L01011
106.36 -5 (-4.34%)
  • As on 31 Mar 2025 (EOD)

  • Today’s Low

    105.00

  • Today’s High

    112.50

  • Open

    111.55

  • Perv Close

    111.18

  • 52W Low

    73.25

  • 52W High

    198.86

Key Indicators

  • P/E(TTM)

    160.81

  • Mar.Cap (₹Cr.)

    279.16

  • Div & Yield %

    0.00

  • Book Value(₹)

    26.77

  • Debt-Equity Ratio

    -4.34

  • AGM Date

    28-Mar-2025

  • EPS

    0.67

  • P/E Ratio

    160.81

Financials Ratios

  • Debt-Equity Ratio

    0.09

  • Mar.Cap (₹Cr.)

    279.16

  • RONW (%)

    0.00

  • ROCE (%)

    0.00

Score Board

  • Equity (₹ in Cr.)

    26.25

  • BV (₹)

    26.80

  • Sales( ₹ in Cr.)

    79.49

  • NP (in Cr.)

    1.52

  • NP Var(%)

    119.0

  • Div%

    0.0

  • CPS (₹)

    1.30

  • EPS (₹)

    0.60

  • Traded Value (₹ in Lakhs)

    282.78

  • 52 Week High

    198.86

  • 52 Week Low

    73.25

  • Price BSE

    108.0

  • Price NSE

    106.00

  • Market Capital( in Cr.)

    282.78

  • P/C Ratio

    86.00

  • P/E Ratio

    186.40

  • Price Vs.BV

    0.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 79.49 55.54 76.97 77.27 69.69 55.03
Excise Duty 79.01 53.49 74.69 77.07 69.13 55.03
Net Sales 79.49 55.54 76.97 77.27 69.69 55.03
Other Income 0.96 0.12 0.95 0.96 0.41 2.88
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 80.44 55.65 77.91 78.23 70.09 57.91
EXPENDITURE :
Raw Materials 79.01 53.49 74.69 77.07 69.13 55.03
Power & Fuel Cost 79.01 53.49 74.69 77.07 69.13 55.03
Employee Cost 10.54 11.54 12.80 14.37 13.38 12.19
Other Manufacturing Expenses 1.07 1.50 1.75 2.63 3.08 3.05
Selling & Administrative Expenses 3.60 4.02 4.47 4.24 3.66 2.71
Miscellaneous Expenses 1.07 1.50 1.75 2.63 3.08 3.05
Less : Pre-operative Expenses Capitalised :
Total Expenditure 78.89 63.84 77.25 86.67 83.61 72.86
Operating Profit 4.44 3.83 6.80 7.32 6.65 6.01
Interest 0.84 0.77 0.67 3.25 3.35 2.96
Gross Profit 1.55 -8.18 0.67 -8.44 -13.51 -14.95
Depreciation 1.77 1.72 1.49 7.09 6.65 6.50
Profit Before Tax 1.55 -8.18 0.67 -8.44 -13.51 -14.95
Tax 0.00 0.00 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 1.74 -0.14
Reported Net Profit 1.53 -8.18 0.67 -15.59 -24.38 -14.81
Extraordinary Items 1.55 -8.18 0.67 -8.44 -13.51 -14.95
Adjusted Net Profit 1.53 -8.18 0.67 -15.59 -24.38 -14.81
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 1.53 -8.18 0.67 -15.59 -24.38 -14.81
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 0.58 -3.32 0.27 -6.31 -13.84 -8.91
Book Value 0.00 0.00 0.00 0.00 0.00 0.00
Book Value(Adj)-Unit Curr 0.00 0.00 0.00 0.00 0.00 0.00

Shareholding Pattern

  • Promoter Group

    52.62%

  • Public Share Holding

    47.38%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 15,500,292 52.62 15,500,292 9
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 15,500,292 52.62 15,500,292 9
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 795 0.00 795 1
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 2,916,111 9.90 2,916,111 1
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 2,916,906 9.90 2,916,906 2
2] Non Institution
Bodies Corporate 1,117,429 3.79 1,117,429 73
Clearing Members 4,460 0.02 4,460 2
Directors of their Relatives 100 0.00 100 1
Employees 6,141 0.02 4,813 6
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 190,516 0.65 190,516 133
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 255,964 0.87 255,964 233
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 4,057,672 13.77 4,057,672 63
Individuals holding nominal share capital up to Rs. 1 lakh 5,407,768 18.36 5,407,396 9,852
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 11,040,050 37.48 11,038,350 10,363
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 29,457,248 100.00 29,455,548 10,374

Company Background

Brooks Laboratories LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Brooks Laboratories Ltd
  • BSE Code : 40505.0
  • ISIN : INE650L01011

  • Incorporation Year

    2002

  • Registered Office

    Village Kishanpura
    Nilagarh Road Baddi, Solan,
    Himachal Pradesh-174101

  • Telephone

    91-1795-654001/02/03

  • FAX

    91-1795-236939

  • Chairman

  • Managing Director

  • Company Secretary

  • Auditor

    DMKH & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Brooks Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Brooks Lab. 107.74 80.44 79.49 160.81 2.72
Abbott India 30,730.65 6,097.18 5,848.91 48.94 44.71
Astrazeneca Phar 8,606.35 1,330.33 1,295.53 221.87 33.26
P & G Health Ltd 5,142.30 1,166.89 1,151.26 36.08 39.76
Glaxosmi. Pharma 2,877.30 3,530.73 3,407.25 57.21 44.44
Cipla 1,441.70 17,645.00 16,574.34 24.72 20.10
Amrutanjan Healt 644.85 437.58 421.23 37.80 20.84
Guj. Themis Bio. 281.50 174.19 169.82 58.28 44.82
Fermenta Biotec. 273.55 315.24 307.09 25.93 4.10
Bliss GVS Pharma 117.55 638.96 605.46 26.90 11.19
Ambalal Sarabhai 35.05 11.70 3.81 14.98 1.92